Home / Articles / Nephrostomy Tubes After Kidney Stone Surgery

Articles

Nephrostomy Tubes After Kidney Stone Surgery

Nephrostomy Tubes After Kidney Stone Surgery: Do You Always Need One?

Introduction

Percutaneous nephrolithotomy — threading instruments through the skin directly into the kidney to remove large or complex stones — is one of the most effective procedures in urological surgery. For stones exceeding 2 centimeters, impacted staghorn calculi, or stones that have failed less invasive approaches, PCNL achieves stone-free rates that shock wave lithotripsy and ureteroscopy simply cannot match.

Yet for decades, the procedure came with an almost universal companion: the nephrostomy tube — a drainage catheter left indwelling through the flank into the kidney at the end of surgery. Originally designed to ensure urinary drainage, allow access for second-look procedures, and tamponade post-operative bleeding, the nephrostomy tube became a fixture of PCNL — accepted as necessary, rarely questioned.

Then surgeons began asking a fundamental question: is it always needed? Can selected patients safely forego the tube — and recover faster? And specifically, does intraoperative bleeding make tube placement mandatory? A randomized controlled trial published in the Iranian Urology Journal addresses exactly this question.

Percutaneous Nephrolithotomy: The Procedure

What PCNL Is and Why It Matters

Percutaneous nephrolithotomy is the gold standard surgical treatment for:

Kidney stones > 20 mm (2 cm) in diameter
Staghorn calculi — branching stones filling the renal collecting system
Lower pole stones > 10–15 mm where ESWL clearance is poor due to gravity-dependent fragment drainage
Stones resistant to ESWL (calcium oxalate monohydrate, cystine stones)
Stones with complex anatomy (infundibular stenosis, malrotation)
Failed prior minimally invasive procedures

The Procedure Step by Step

PCNL is performed under general or spinal anesthesia, typically in the prone position:

Ureteric catheter placement — retrograde ureteric catheter placed cystoscopically to opacify the collecting system
Fluoroscopic or ultrasound-guided puncture — a needle is advanced through the flank skin into the targeted renal calyx
Tract dilation — the nephrostomy tract is progressively dilated to 24–30 French (approximately 8–10 mm) to allow passage of the working sheath
Stone fragmentation — through the access sheath, a nephroscope is introduced and stones fragmented with ultrasonic, pneumatic, or laser energy
Fragment extraction — pieces removed with graspers or flushed out
Post-operative drainage decision — the critical branching point: place a nephrostomy tube, a ureteric stent, or nothing (tubeless)?

Stone-Free Rates

PCNL achieves stone-free rates of:

Single access: 75–90% for stones 20–40 mm
Staghorn calculi: 60–85% (often requiring multiple sessions)
Substantially superior to ESWL for large stones: ESWL achieves only 40–60% stone-free for stones > 20 mm

The Nephrostomy Tube: Origins and Rationale

Traditional Indications for Leaving a Tube

The nephrostomy tube — a 14–20 French drain placed through the access tract into the renal pelvis — became standard after PCNL for several sound reasons:

Urinary drainage: ensures urine drains freely if the ureter is obstructed by edema, clot, or residual fragments
Hemostasis: the tube tamponades the access tract, compressing bleeding vessels within the parenchyma
Second-look access: allows return to the kidney the following day for a “second-look nephroscopy” to retrieve residual fragments without creating a new tract
Leak prevention: prevents urinary extravasation from the collecting system through the access tract
Safety margin: provides drainage if unexpected post-operative complications develop

These rationales were compelling enough that for many years, virtually all PCNL procedures ended with a nephrostomy tube in situ.

The Cost of the Tube

Despite its safety rationale, the nephrostomy tube carries real costs:

Pain: the tube itself is a significant source of post-operative discomfort, often more painful than the flank incision
Hospital stay: standard tube removal at 24–48 hours mandates a minimum inpatient stay
Activity restriction: tube management limits patient mobility and return to function
Tube-related complications: dislodgement, blockage, infection around the exit site
Urinary leakage: around the tube or after removal
Healthcare costs: additional nursing care, supplies, and hospitalization days

As surgeons accumulated PCNL experience and outcomes data improved, the question naturally arose: could the tube be safely omitted in appropriate cases?

The Evolution Toward Tubeless PCNL

Defining the Spectrum

The terminology in this field describes a spectrum of post-operative drainage strategies:

Approach	Description	Components
Standard PCNL	Nephrostomy tube in renal pelvis	Large-bore (16–20 Fr) nephrostomy tube
Small-bore PCNL	Smaller nephrostomy tube	8–12 Fr tube; less discomfort
Modified tubeless PCNL	Ureteric stent only; no nephrostomy	Internal JJ (double-J) stent; no external tube
Totally tubeless PCNL	No nephrostomy tube; no stent	Nothing internal or external post-op
Ultra-mini PCNL	Very small access (11–13 Fr)	Often tubeless; fragmentation only

The shift toward tubeless and totally tubeless approaches has been one of the most significant trends in PCNL over the past 15 years.

Evidence for Tubeless Approaches

A robust body of evidence from randomized controlled trials and meta-analyses supports tubeless PCNL in selected patients:

Multiple randomized trials have demonstrated that tubeless PCNL is associated with significantly less post-operative pain, shorter hospital stay, and equivalent stone-free rates compared to standard nephrostomy tube placement in uncomplicated cases.

Meta-analyses confirm:

Pain scores: significantly lower with tubeless approaches (typically 2–3 points on visual analog scale)
Hospital stay: reduced by 1–2 days with tubeless PCNL
Analgesic requirement: meaningfully reduced
Stone-free rates: equivalent to standard PCNL in appropriately selected patients
Complication rates: not significantly different in uncomplicated cases

The Bleeding Question: When Does Hemorrhage Change the Calculus?

Hemorrhage as a PCNL Complication

Bleeding is the most common and potentially most serious complication of PCNL. The kidney is a highly vascular organ — the renal cortex receives approximately 20% of cardiac output — and needle puncture, tract dilation, and nephroscopy all carry hemorrhagic risk.

Clinically significant bleeding in PCNL manifests as:

Intraoperative bleeding obscuring visualization (requiring early termination)
Post-operative hemoglobin drop requiring transfusion (occurs in 5–10% of standard PCNL cases)
Delayed arterial bleeding from pseudoaneurysm or arteriovenous fistula (occurs in 0.5–1.5%; requires angioembolization)
Clot retention in the collecting system causing obstruction

Risk factors for significant PCNL bleeding include:

Multiple access tracts
Upper pole puncture (intercostal approach)
Large stone burden requiring prolonged nephroscopy
Staghorn calculi with extensive intrarenal dissection
Abnormal coagulation or antiplatelet medication
Operator inexperience

The Clinical Assumption — and Why It Was Challenged

For decades, clinical practice assumed that if intraoperative bleeding occurred during PCNL, a nephrostomy tube was mandatory — to tamponade the tract and ensure drainage in the setting of potential clot formation. This assumption was so deeply embedded that it was rarely tested.

The RCT published in the Iranian Urology Journal challenged this assumption directly: does bleeding during PCNL actually necessitate keeping the nephrostomy tube? The study randomized patients who experienced intraoperative bleeding to either standard nephrostomy tube placement or modified tubeless PCNL, measuring subsequent outcomes.

What the RCT Found

The study’s findings are clinically significant and counter-intuitive for many practitioners:

Patients with intraoperative bleeding randomized to tubeless management did not have significantly higher rates of serious post-operative hemorrhage compared to tube-managed patients
The nephrostomy tube did not demonstrably reduce transfusion rates or angioembolization requirements in this setting
Tubeless patients reported significantly less pain and shorter hospitalization
Complication rates were comparable between groups

The implication: the reflex to place a nephrostomy tube in the presence of intraoperative bleeding may not be evidence-based for a substantial proportion of patients — those with moderate bleeding that is controlled by the time the procedure concludes.

Patient Selection: Who Is and Is Not a Candidate for Tubeless PCNL?

Appropriate Candidates for Tubeless PCNL

Based on current evidence, the following patients are generally considered suitable for tubeless or modified tubeless PCNL:

Stone-free status achieved at the end of the procedure (no planned second-look)
Single access tract
Absence of significant collecting system perforation
Bleeding that has been controlled before end of procedure (even if present intraoperatively)
No evidence of ureteral obstruction (verified by retrograde pyelogram)
No infection (sterile pre-operative urine culture)
Normal contralateral kidney (single-kidney patients warrant greater caution)
Uncomplicated operative course

Patients Who Should Retain a Nephrostomy Tube

Despite the evolving evidence favoring tubeless approaches, certain situations clearly warrant nephrostomy tube placement:

Indication	Reason for Tube
Residual stones requiring second-look	Access preservation for next-day nephroscopy
Significant perforation of collecting system	Drainage essential to prevent urinary extravasation
Uncontrolled active arterial bleeding at end of procedure	Tamponade and drainage critical
Solitary functioning kidney	No contralateral backup; maximum safety required
Active urinary infection / staghorn struvite	Ongoing sepsis risk; drainage reduces bacterial load
Significant ureteral injury	Antegrade stenting via nephrostomy
Planned staged procedure	Access preservation
Pediatric PCNL (selected cases)	Smaller margin for error
Surgeon inexperience with tubeless technique	Learning curve safety

Perioperative Assessment Tools

The decision to place or omit the nephrostomy tube should ideally be based on objective intraoperative assessment:

End-procedure nephrostogram: contrast injected through the access sheath to visualize the collecting system — perforations, obstruction, and completeness of stone clearance assessed
Visual estimation of bleeding: experienced surgeons assess whether bleeding has controlled adequately by procedure end
Ureteral integrity: retrograde pyelogram confirms unobstructed drainage to bladder
Hemostatic parameters: coagulation indices, estimated blood loss during procedure

Comparative Outcomes: Standard vs. Tubeless Approaches

Outcome	Standard (Nephrostomy Tube)	Modified Tubeless (JJ Stent)	Totally Tubeless
Post-op pain (VAS 0–10)	5–7	3–5	2–4
Analgesic doses required	Higher	Moderate	Lowest
Hospital stay (days)	2–4	1–2	1
Transfusion rate	3–8%	3–8%	3–7%
Stone-free rate	Baseline	Equivalent	Equivalent
Urinary leakage/extravasation	1–3%	1–3%	1–3%
Fever/UTI post-op	8–15%	8–15%	8–15%
Return to activity	5–7 days	3–5 days	2–4 days
Stent-related symptoms	None	LUTS in 20–30%	None
Patient satisfaction	Moderate	High	Highest

The Future: Mini and Ultra-Mini PCNL

The evolution toward less invasive PCNL has continued beyond the nephrostomy tube debate to the access tract itself. Mini-PCNL (11–20 Fr tracts versus the standard 24–30 Fr) and ultra-mini PCNL (< 11 Fr) have been developed to reduce parenchymal injury and bleeding risk:

Smaller tracts → less bleeding → easier tubeless management
Trade-off: longer operative time for large stone burdens; fragmentation efficiency reduced
Suitable for stones 10–20 mm; increasingly used for 20–30 mm stones in experienced hands

The combination of mini access with tubeless exit represents the current frontier of outpatient PCNL — procedures performed in day-surgery settings with same-day discharge in appropriately selected patients.

Conclusion

The traditional assumption that intraoperative bleeding during PCNL automatically mandates nephrostomy tube placement is being rigorously challenged by randomized controlled trial evidence — including the Iranian Urology Journal study that directly addressed this specific question. For carefully selected patients where intraoperative bleeding is controlled, tubeless PCNL appears safe and offers meaningful benefits: less pain, shorter hospitalization, faster recovery, and higher patient satisfaction — without increasing transfusion requirements or serious hemorrhagic complications.

This does not mean nephrostomy tubes are obsolete — they remain essential for specific high-risk situations, planned second-look procedures, and patients with inadequate urinary drainage. The message for modern PCNL practice is nuance and individualization: the tube should be placed when clinically indicated, not reflexively because bleeding occurred.

Your next steps if PCNL has been recommended:

Ask your urologist whether a tubeless or modified tubeless approach is appropriate for your specific stone and anatomy
Discuss what criteria would be used intraoperatively to decide tube placement — this should be a planned decision, not entirely reactive
If you have a pacemaker, bleeding disorder, or solitary kidney, understand why these may mandate standard tube placement for your safety
Ask about mini-PCNL as an option — smaller tracts may reduce bleeding risk and facilitate tubeless management
Ensure pre-operative urine culture is performed and any infection treated before PCNL
Discuss realistic recovery timelines — tubeless PCNL patients typically return to normal activities within 3–5 days versus 5–7 days for tube-managed patients